Literature DB >> 29624637

MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab.

E Mensà1, R Recchioni2, F Marcheselli2, K Giuliodori3, V Consales3, E Molinelli3, F Prattichizzo4, M R Rippo1, A Campanati3, A D Procopio1,2, F Olivieri1,2, A M Offidani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29624637     DOI： 10.1111/bjd.16659

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

Review 1.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

2.  Serum Levels of miR-146a in Patients with Psoriasis.

Authors:  Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M Silva; Manuela Selores; Paulo P Costa; Tiago Torres
Journal:  Mol Diagn Ther       Date:  2021-05-02       Impact factor: 4.074

3.  Diagnostic performance of new and classic CSF biomarkers in age-related dementias.

Authors:  Giuseppe Pelliccioni; Fabiola Olivieri; Francesca Marchegiani; Giulia Matacchione; Deborah Ramini; Fiorella Marcheselli; Rina Recchioni; Tiziana Casoli; Elisa Mercuri; Marco Lazzarini; Belinda Giorgetti; Valentina Cameriere; Susy Paolini; Lucia Paciaroni; Tommaso Rossi; Roberta Galeazzi; Rosamaria Lisa; Anna Rita Bonfigli; Antonio Domenico Procopio; Maria De Luca
Journal:  Aging (Albany NY)       Date:  2019-04-27       Impact factor: 5.682

Review 4.  Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.

Authors:  Xiaomin Liu; Yang Shao; Jinbao Zhou; Guangren Qian; Zhongliang Ma
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

5.  Expression of miR-135b in Psoriatic Skin and Its Association with Disease Improvement.

Authors:  Pablo Chicharro; Pedro Rodríguez-Jiménez; Mar Llamas-Velasco; Nuria Montes; Ancor Sanz-García; Danay Cibrian; Alicia Vara; Manuel J Gómez; María Jiménez-Fernández; Pedro Martínez-Fleta; Inés Sánchez-García; Marta Lozano-Prieto; Juan C Triviño; Rebeca Miñambres; Francisco Sánchez-Madrid; Hortensia de la Fuente; Esteban Dauden
Journal:  Cells       Date:  2020-07-02       Impact factor: 6.600

Review 6.  MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.

Authors:  Sandra Domingo; Cristina Solé; Teresa Moliné; Berta Ferrer; Josefina Cortés-Hernández
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

7.  The effect of TNF-α inhibitor treatment on microRNAs and endothelial function in collagen induced arthritis.

Authors:  Sulè Gunter; Frederic S Michel; Serena S Fourie; Mikayra Singh; Regina le Roux; Ashmeetha Manilall; Lebogang P Mokotedi; Aletta M E Millen
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

Review 8.  Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.

Authors:  Shih-Chun Yang; Ahmed Alalaiwe; Zih-Chan Lin; Yu-Chih Lin; Ibrahim A Aljuffali; Jia-You Fang
Journal:  Biomolecules       Date:  2022-08-03

Review 9.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10

10.  MicroRNA-146a and microRNA-146b deficiency correlates with exacerbated disease activity, and their longitude increment relates to etanercept response in psoriasis patients.

Authors:  Hui Shen; Dan Wang; Mengyun Zhan; Hanping Ding; Hongbo Zhao
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.